Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 8th September 2015
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

PCV2 vaccine approved for pregnant sows
piglets
PCV2 can have a devastating impact on pig health, as well as economic losses for farmers.
Vaccine is a first in the EU
 
A vaccine to protect against porcine circovirus type 2 (PCV2) has now been approved for use in pregnant and lactating sows.

The European Medicines Agency has authorised this use of the Ingelvac CircoFLEX, which was developed by Boehringer Ingelheim.

According to the head of the pharma company, George Heidgerken, this is the first PCV2 vaccine to be licensed in the EU for the protection of both piglets and sows.

PCV2 can have a devastating impact on pig health, as well as economic losses for farmers. Infection may lead to wasting, paleness of the skin, dyspnea or diarrhoea in piglets and, in breeding sows, can result in reproductive losses.

In both piglets and sows, the virus can also cause subclinical infections.

According to Boehringer, Ingelvac CircoFLEX reduces mortality, clinical signs and lesions associated with PCV2.

In addition, the company says studies have shown vaccinating sows has 'significant positive effects' on reproductive performance and the number of piglets born alive and weaned.

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
BSAVA publishes fifth Manual of Canine and Feline Neurology

The BSAVA has published the fifth edition of its BSAVA Manual of Canine and Feline Neurology.

The new edition has been reviewed and updated, including new developments in diagnostics, therapeutic approaches and clinical decision-making. It is structured to support clinicians through diagnosis, treatment and long-term management.

The guide features five new chapters covering acute myelopathies, chronic myelopathies, emergency protocols, neurotoxicology and neuro-oncology.

It also includes over 100 videos, including demonstrations of neurological examinations, clinical presentations and diagnostic procedures.

Nicola Lloyd, publishing manager, said: "Whether you're a general practitioner seeking practical guidance, or a specialist aiming to refine your expertise, this edition remains an indispensable reference for anyone involved in the care of neurologically compromised dogs and cats."